Augmentin ES 600 mg Suspension
PDF Leaflet Revision Date: 19 February 2026
Clinical Summary
Quick overview from the medicine insert
Indication
Short term treatment of acute bacterial otitis media.
Dosage (summary)
90/6.4 mg/kg/day in two divided doses for children aged 3 months and older.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Safety in pregnancy not established; avoid breastfeeding during treatment.
Key Drug Interactions
- Probenecid
- Allopurinol
- Oral anticoagulants
Contraindications
- Hypersensitivity to penicillins
- History of AUGMENTIN-associated jaundice
Common side effects
- Diarrhoea
- Nausea
- Vomiting
- Skin rash
Counselling Points
- Take before meals
- Monitor for allergic reactions
- Avoid alcohol during treatment
Serious warnings
- Serious hypersensitivity reactions
- Pseudomembranous colitis
Important Disclaimer
The Augmentin ES 600 mg Suspension professional information leaflet below is the property of Glaxosmithkline South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
